BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Metabolic associated fatty liver disease
1
Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomes
4/20/2023 7:26:29 AM | Browse: 320 | Download: 882
2
Prognostic performance of an index based on lactic dehydrogenase and transaminases for patients with liver steatosis and COVID-19
9/29/2022 10:42:42 AM | Browse: 643 | Download: 2353
3
Non-alcoholic fatty liver disease: Is surgery the best current option and can novel endoscopy play a role in the future?
9/23/2022 12:48:56 AM | Browse: 545 | Download: 1091
4
Metabolic-associated fatty liver disease is associated with low muscle mass and strength in patients with chronic hepatitis B
8/26/2022 9:51:35 AM | Browse: 398 | Download: 1484
5
Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease
4/30/2022 5:08:22 AM | Browse: 567 | Download: 1664
6
Comments on validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease
2/9/2022 7:25:27 AM | Browse: 555 | Download: 1406
7
Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?
1/21/2022 8:16:14 AM | Browse: 596 | Download: 1246
8
Gut dysbiosis and systemic inflammation promote cardiomyocyte abnormalities in an experimental model of steatohepatitis
12/27/2021 5:24:00 AM | Browse: 595 | Download: 1685
9
Probiotics in hepatology: An update
9/22/2021 8:09:41 AM | Browse: 733 | Download: 1675
10
Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease
9/9/2021 6:46:56 AM | Browse: 562 | Download: 1500
11
Clinical perspectives, assessment, and mechanisms of metabolic associated fatty liver disease in patients with COVID-19
9/3/2021 11:45:55 AM | Browse: 725 | Download: 1217
12
Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence
8/20/2021 9:33:19 AM | Browse: 837 | Download: 1788
13
Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease
8/10/2021 6:48:42 AM | Browse: 622 | Download: 1291
14
Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic associated fatty liver disease
4/9/2021 9:07:56 AM | Browse: 778 | Download: 1979
15
Clinic-pathological features of metabolic associated fatty liver disease with hepatitis B virus infection
1/25/2021 6:05:27 AM | Browse: 529 | Download: 1931
16
Metabolic associated fatty liver disease: Addressing a new era in liver transplantation
12/18/2020 5:58:43 AM | Browse: 895 | Download: 1494
17
Macrophages in metabolic associated fatty liver disease
4/28/2020 8:04:30 AM | Browse: 997 | Download: 1588
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345